<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Chronic peritoneal dialysis in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Chronic peritoneal dialysis in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Chronic peritoneal dialysis in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Annabelle Chua, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bradley A Warady, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Patrick Niaudet, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 10, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H15616673"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Chronic peritoneal dialysis (CPD) is the most common dialysis treatment modality used to treat pediatric patients with end-stage kidney disease (ESKD), particularly in children less than five years of age [<a href="#rid1">1-3</a>]. CPD offers several advantages over hemodialysis (HD) that are beneficial for children; however, there are clinical settings in which CPD is contraindicated or may not be the best dialytic modality. In addition, although the principles of CPD are the same for pediatric and adult patients, there are aspects of CPD that are unique to children and infants, which need to be addressed to ensure the adequacy of dialysis and to reduce complications for the pediatric patient.</p><p>The various aspects of CPD in children will be reviewed here. Overview of kidney replacement therapy (KRT) in children and hemodialysis for children with chronic kidney disease are presented separately. (See  <a class="medical medical_review" href="/d/html/16179.html" rel="external">"Overview of kidney replacement therapy for children with chronic kidney disease"</a> and  <a class="medical medical_review" href="/d/html/14562.html" rel="external">"Hemodialysis for children with chronic kidney disease"</a>.)</p><p>The general mechanisms of the removal of solute and fluid during CPD are the same in the adult and pediatric patient and are also discussed separately. (See  <a class="medical medical_review" href="/d/html/1878.html" rel="external">"Mechanisms of solute clearance and ultrafiltration in peritoneal dialysis"</a>.)</p><p class="headingAnchor" id="H3926445"><span class="h1">PERITONEAL DIALYSIS VERSUS HEMODIALYSIS</span><span class="headingEndMark"> — </span>There have not been any comparative studies of peritoneal dialysis (PD) and hemodialysis (HD) outcomes in children with end-stage kidney disease (ESKD) to suggest superiority of one procedure versus the other. While the majority of pediatric patients with ESKD who require dialysis can be managed with CPD, the choice of dialysis modality is most often based on patient and family preference, center philosophy, and availability of the desired modality.</p><p>The quality of life for both patient and family assumes great importance in the selection of home dialysis therapy as a result of the "burden of care" associated with this approach to ESKD management. As such, careful evaluation of the family's social, psychological, and economic background, ideally by a multiprofessional team including the family clinician and nephrologist, dialysis nurse, psychologist, and social worker, is mandatory if a fully informed decision regarding modality selection is to be made [<a href="#rid4">4-6</a>].</p><p>Although both HD and CPD are effective in solute and fluid removal, CPD offers the following advantages over HD in children [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Less restricted diet including fluid intake because CPD is performed daily. This is particularly beneficial for infants in whom nutritional intake is exclusively or mainly dependent upon a liquid diet.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Therapy is performed at home, thereby allowing for regular school attendance and participation in other normal childhood activities. For those who live a long distance from a hemodialysis center, there is no need to travel to the unit three or more times per week for dialysis treatments.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No vascular access and the associated need for repeated venipuncture (arteriovenous fistula/graft) or the risk for bacteremia (central venous catheter). In particular, vascular access for hemodialysis is challenging in patients less than two years of age. (See  <a class="medical medical_review" href="/d/html/14562.html" rel="external">"Hemodialysis for children with chronic kidney disease", section on 'Vascular access'</a>.)</p><p></p><p>Disadvantages of CPD include, but are not limited to:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased caregiver burden, which may lead to psychological and social stress [<a href="#rid8">8,9</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Possible patient/caregiver nonadherence to prescribed therapy</p><p class="bulletIndent1"><span class="glyph">●</span>Risk of CPD-related infections, such as PD catheter exit site/tunnel infections and peritonitis</p><p></p><p class="headingAnchor" id="H15616680"><span class="h2">Contraindications to CPD</span><span class="headingEndMark"> — </span>The only absolute contraindications to CPD include conditions that affect the integrity of the abdominal cavity and peritoneum including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Omphalocele</p><p class="bulletIndent1"><span class="glyph">●</span>Gastroschisis</p><p class="bulletIndent1"><span class="glyph">●</span>Bladder exstrophy</p><p class="bulletIndent1"><span class="glyph">●</span>Diaphragmatic hernia</p><p class="bulletIndent1"><span class="glyph">●</span>Obliterated peritoneal cavity and peritoneal membrane failure</p><p></p><p>Relative contraindications to CPD include:</p><p class="bulletIndent1"><span class="glyph">●</span>Impending abdominal surgery.</p><p class="bulletIndent1"><span class="glyph">●</span>Scheduled (&lt;3 months) living-donor kidney transplantation, as the efforts and resources required for training may not be justified for short term provision of CPD. However, CPD might be considered if hemodialysis is not a viable option.</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of an appropriate caregiver for home therapy.</p><p class="bulletIndent1"><span class="glyph">●</span>Patient/caregiver choice for HD, which is available and medically suitable.</p><p></p><p>Controversy exists as to whether the presence of a ventriculoperitoneal shunt constitutes a contraindication to CPD. Limited experience suggests that CPD is acceptable in this situation if no feasible alternative dialysis option exists, recognizing the potential infection-related risks [<a href="#rid10">10</a>].</p><p>On the other hand, the presence of a colostomy [<a href="#rid11">11</a>], gastrostomy, ureterostomy, and/or pyelostomy does not preclude CPD. However, data from the International Pediatric Peritoneal Dialysis Registry (IPPN) revealed an increased risk of peritonitis in patients who had a colostomy [<a href="#rid11">11</a>]. Patients with prune-belly syndrome have also been successfully managed with CPD [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H15616702"><span class="h1">PRESCRIBING PERITONEAL DIALYSIS</span><span class="headingEndMark"> — </span>Selection of the peritoneal dialysis (PD) modality and the specific prescription components should ideally be tailored to the needs of the individual patient, with consideration of the medical needs of the child and the quality of life of the patient and family [<a href="#rid5">5,13,14</a>]. These choices are based on the child's age, body size, residual kidney function (RKF), associated nonrenal diseases, nutritional status, and transport characteristics of the peritoneal membrane, as well as the social, educational, and economic status of the family.</p><p class="headingAnchor" id="H21423824"><span class="h2">Pediatric versus adult PD</span><span class="headingEndMark"> — </span>Specific issues for children undergoing CPD that differ from the adult patient include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fill volume</strong> is based on the body surface area (BSA) of the child (<a class="calc calc_professional" href="/d/html/13406.html" rel="external">calculator 1</a>). (See <a class="local">'Fill volume'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peritoneal equilibration test (PET)</strong> – PET is used to evaluate the peritoneal membrane function (see <a class="local">'Peritoneal membrane function'</a> below). When performing this test, instead of the standard 2 L fill volume used for the PET in adults, a test volume of 1100 mL/m<sup>2</sup> based on the patient's BSA is typically used in children. However, infants and young children (below two years of age) may not tolerate a test volume of 1100 mL/m<sup>2</sup>. In these patients, the test volume generally used is the clinically prescribed fill volume. (See <a class="local">'Peritoneal membrane function'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PD catheter size and placement</strong> – Size of PD catheter will vary based on size of the child. In addition, attention to location of the PD catheter exit site is important in infants still wearing diapers as well as in patients who have a gastrostomy tube or some other stoma (eg, colostomy). (See <a class="local">'PD catheter'</a> below.)</p><p></p><p class="headingAnchor" id="H170768844"><span class="h2">Choice of modality</span><span class="headingEndMark"> — </span>For both children and adults, PD modalities are divided into manual and automated options:</p><p class="bulletIndent1"><span class="glyph">●</span>Continuous ambulatory peritoneal dialysis (CAPD)</p><p class="bulletIndent1"><span class="glyph">●</span>Automated peritoneal dialysis (APD)</p><p></p><p class="headingAnchor" id="H170768851"><span class="h3">Continuous ambulatory PD</span><span class="headingEndMark"> — </span>Continuous ambulatory peritoneal dialysis (CAPD) provides continuous solute and fluid removal throughout the day and night. In this manual form of CPD, the patient or caregiver attaches and instills a bag of sterile dialysis fluid into the peritoneal cavity four times per day through a surgically placed catheter, followed by drainage through the same catheter after a predetermined period of time (referred to as the dwell time). The filling and draining of fluid constitutes an exchange. Each of the three daytime exchanges lasts approximately five hours, and the nighttime exchange nine hours. The advantages of CAPD are its ease of use and the limited cost of equipment. CAPD is a modality that is often used in developing countries where there is a lack of access to automated PD and chronic HD [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H170768858"><span class="h3">Automated PD</span><span class="headingEndMark"> — </span>APD is broadly defined as all forms of PD that employ the use of a cycler [<a href="#rid5">5,13</a>]. If it is available and there are no financial constraints, APD is the preferred modality for pediatric patients because it allows for a wide range of treatment options, which is more easily tailored than CAPD to the individual needs of the child. In addition, the risk of peritonitis may be less in patients receiving APD as compared with CAPD [<a href="#rid16">16</a>].</p><p>In general, multiple automated exchanges are performed at night while the patient is sleeping. The supine position is superior to the upright position for solute and fluid transport because there is better tolerance of large fill volumes, which increases the contact area of the peritoneal membrane and dialysate.</p><p>There are currently three APD options that include multiple nocturnal exchanges:</p><p class="bulletIndent1"><span class="glyph">●</span>Nightly intermittent PD (NIPD) – In NIPD, there are a number of short automated nocturnal exchanges, but no dialysis exchange during the day. Thus, solute and fluid removal only take place at night.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Advantages of a dry peritoneal cavity during the day include normal intraperitoneal pressure (IPP) and a decreased risk for hernia formation, reduction of glucose absorption from dialysate, reduction of amino acid and protein loss, and reduction of peritoneal membrane exposure to glucose. In addition, the absence of fluid in the peritoneal cavity might result in improved appetite. (See <a class="local">'Mechanical complications'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The absence of a daytime dwell volume limits solute clearance; thus, NIPD is generally not a suitable choice in patients with little or no RKF.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Continuous cycling peritoneal dialysis (CCPD) – In CCPD, automated nocturnal exchanges are followed by a prolonged daytime exchange (dialysis solution volume of 50 to 100 percent of the nocturnal volume), applied at the conclusion of the nocturnal APD session and left in the peritoneal cavity until the start of the next nocturnal dialysis session.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CCPD provides continuous solute and fluid removal throughout the day and night.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CCPD is recommended when RKF becomes negligible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tidal peritoneal dialysis (TPD) – In TPD, an initial infusion of dialysis solution into the peritoneal cavity is followed by only partial drainage of the dialysis solution during each exchange. As a result, an intraabdominal volume of dialysate is retained at the end of each exchange, so there is constant contact between dialysis solution and the peritoneal membrane.</p><p></p><p class="bulletIndent1">Partial drain volume is replaced by fresh dialysate to restore the initial fill volume with each cycle. The entire dialysate volume is drained at the end of the session.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>TPD provides continuous solute and fluid removal throughout the day and night.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>It is commonly used for patients with mechanical (eg, drainage of dialysate) problems and as a means of alleviating discomfort in patients experiencing drainage pain [<a href="#rid17">17</a>]. (See <a class="local">'Noninfectious complications'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The tidal drain volume can be adapted to the drainage profile of the patient to increase dialysis efficiency. The rate of outflow is not linear and is highest at the beginning of the drain time and then significantly drops to a breakpoint when a critical intraperitoneal volume is reached. Elimination of the time at this breakpoint necessary for complete drainage decreases the time period when solute clearance is greatly reduced.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>TPD requires more dialysate solution and is technically more difficult to perform than CCPD or NIPD.</p><p></p><p>APD is performed through a specific pediatric mode of the cycler, which has been adapted for use in infants, children, and adolescents. In small children and infants, this allows for more accurate delivery of small dialysate volumes. As a result of technological advancements, software computer programs can record adherence to the dialysis prescription, delivered dialysate volume, the amount of fluid removed (eg, ultrafiltrate), and the drainage profile of each exchange. This information can be downloaded from the memory card of the cycler or be retrieved via a modem on a regular basis and is used to improve and update the PD prescription [<a href="#rid18">18</a>]. Remote monitoring of APD is also available and allows for more personalization of the APD prescription. In adults, remote monitoring results in more frequent modifications of the APD prescription that proactively address clinical issues and helps decrease the need for additional clinic visits [<a href="#rid19">19</a>]. The use of remote monitoring in children on APD is currently being studied. </p><p>Adapted PD, a variation of automated PD, is characterized by sequential short- and longer-dwell exchanges with small and large dwell volumes designed to enhance volume and solute removal, respectively [<a href="#rid20">20</a>]. It still requires further study in children to determine effectiveness.</p><p class="headingAnchor" id="H170770118"><span class="h2">PD catheter</span><span class="headingEndMark"> — </span>Successful CPD is dependent on the placement of a reliable access. A two-cuffed Tenckhoff catheter is preferred because use of double cuff versus single cuff catheters is associated with a lower incidence of peritonitis and access revisions, and a longer time to first peritonitis episode [<a href="#rid21">21-23</a>]. (See  <a class="medical medical_review" href="/d/html/1885.html" rel="external">"Placement of the peritoneal dialysis catheter"</a>.) </p><p>Catheters should be surgically placed in a paramedian or lateral abdominal location. The deep cuff is placed in or below the rectus muscle, and the superficial cuff is located approximately 2 cm below the skin surface. The catheter should be placed with a lateral or downward-facing exit site position to reduce the risk of peritonitis [<a href="#rid21">21,22</a>]. Other considerations include placement of the exit site away from a (or potential) gastrostomy or other ostomy site, and outside the diaper area in infants and small children. Omentectomy should be performed at time of PD catheter placement; in a multicenter retrospective study, it was strongly associated with reduced likelihood of PD catheter revision [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H15616710"><span class="h2">Peritoneal membrane function</span><span class="headingEndMark"> — </span>The transport capacity of a patient's peritoneal membrane is one of the most important characteristics to consider when determining the dialysis prescription. The most widely used test of peritoneal membrane function is the peritoneal equilibration test (PET), which assesses the overall solute transport rates across the peritoneum. It categorizes patients based on their solute transport rates and serves as the basis for the patient's dialysis prescription. (See  <a class="medical medical_review" href="/d/html/1972.html" rel="external">"Peritoneal equilibration test"</a>.)</p><p>In children, this standardized test measures small solute transport across the peritoneal membrane and net ultrafiltration during a four-hour dwell using a fill volume of 1100 mL/m<sup>2</sup> BSA of a 2.5 percent dextrose-containing dialysate [<a href="#rid25">25</a>]. It is important to recognize that the test fill volume significantly impacts the PET results (eg, small volume associated with high measured solute transport capacity). Several studies have validated this test volume for the PET and have shown consistent results that are similar to the results in adults using the standard test fill volume of 2 L [<a href="#rid25">25-28</a>]. Using the BSA-adjusted test volume, there appears to be no difference in the peritoneal membrane transport characteristics between children and adults.</p><p>Infants and young children (below two years of age), however, may not tolerate a test volume of 1100 mL/m<sup>2</sup>. In these patients, the test volume generally used is the clinically prescribed fill volume. (See <a class="local">'Fill volume'</a> below.)</p><p>PET is used clinically as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Initiation of dialysis to determine the dialysis prescription – A PET evaluation is conducted four to eight weeks following the initiation of CPD, with subsequent evaluation and possible modification of the initial PD prescription.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitor membrane function – Because of changes in the peritoneal membrane function that may occur, the PET is used to monitor membrane function and help guide changes in the dialysis prescription. PET should be repeated when there is concern for membrane injury or changes (eg, following repeated episodes of peritonitis) and/or clinical evidence of altered transport characteristics (eg, fluid retention with increased blood pressure or worsening symptoms of uremia).</p><p></p><p>The clinical applications of the PET are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/1972.html" rel="external">"Peritoneal equilibration test", section on 'Clinical applications'</a>.)</p><p class="headingAnchor" id="H15616717"><span class="h2">Prescription components</span><span class="headingEndMark"> — </span>The following are the elements of the peritoneal dialysis prescription after selecting the CPD modality:</p><p class="bulletIndent1"><span class="glyph">●</span>Selection of PD solutions</p><p class="bulletIndent1"><span class="glyph">●</span>Determination of the fill volume</p><p class="bulletIndent1"><span class="glyph">●</span>Determination of dwell time and number of exchanges</p><p></p><p>The prescription is based on the individual patient needs for solute transfer and removal of fluid, both of which can be increased by changes in the prescription, such as increasing the osmolality of the PD solution, fill volume, and/or number of exchanges.</p><p class="headingAnchor" id="H170769273"><span class="h3">Solutions</span><span class="headingEndMark"> — </span>Several different solutions are available commercially for peritoneal dialysis and all include the following components:</p><p class="bulletIndent1"><span class="glyph">●</span>Water</p><p class="bulletIndent1"><span class="glyph">●</span>Buffers to control acidosis (eg, acetate, lactate, or bicarbonate)</p><p class="bulletIndent1"><span class="glyph">●</span>Electrolytes (ie, sodium, calcium, chloride, and magnesium)</p><p class="bulletIndent1"><span class="glyph">●</span>Osmotic agent; usually dextrose in varying concentrations (1.5, 2.5, and 4.25 percent solutions). Increasing the osmolality will increase net fluid removal.</p><p></p><p>Although these solutions satisfactorily remove fluid and transfer solutes, and generally maintain adequate electrolyte, acid-base, and mineral homeostasis, there is increasing evidence that prolonged exposure to standard PD solutions results in membrane injury and reduced function, especially in patients who are exposed to the frequent short cycles used in APD [<a href="#rid5">5,13,29</a>]. In particular, solutions with high concentrations of glucose and lactate appear to be more injurious.</p><p>Therefore, development of more biocompatible solutions is desirable, especially for pediatric patients in whom preserving a functional membrane is important so that CPD can be maintained as a long-term dialysis modality. Amino acids and bicarbonate have been used to improve biocompatibility. A multicenter randomized controlled trial showed that a bicarbonate-based buffer improved long-term preservation of peritoneal membrane function compared with lactate-based PD fluids in children on automated PD, while still achieving equal control of acidosis [<a href="#rid30">30</a>]. However, in a study evaluating the effect of neutral pH and low-glucose degradation product dialysis fluids on the peritoneal membrane, biopsies demonstrated vascular changes with early peritoneal inflammation as early as six months after PD initiation, which may ultimately affect PD membrane transport function [<a href="#rid31">31</a>]. Higher molecular weight glucose polymers, such as <a class="drug drug_general" data-topicid="8769" href="/d/drug information/8769.html" rel="external">icodextrin</a>, can be used during the long dwell (during the night for patients on CAPD and during the day for patients on APD) to enhance ultrafiltration in patients with high peritoneal membrane transport capacity. </p><p>Further studies in children are warranted to see if these or other strategies improve long-term peritoneal membrane function without significant adverse effects [<a href="#rid32">32-34</a>].</p><p>The use of these biocompatible solutions is limited, however, as these solutions are not available in many parts of the world. (See  <a class="medical medical_review" href="/d/html/1905.html" rel="external">"Peritoneal dialysis solutions"</a>.)</p><p class="headingAnchor" id="H170769281"><span class="h3">Fill volume</span><span class="headingEndMark"> — </span>As noted above, an important difference in prescribing CPD for children compared with adults is that the prescribed fill volume is based on the BSA of the child. It is adjusted based on the patient's tolerance and need for solute and fluid removal. (See <a class="local">'Pediatric versus adult PD'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>In a CAPD regimen of four exchanges per day, a fill volume of 900 to 1100 mL/m<sup>2</sup> BSA (35 to 45 mL/kg) of 2.5 percent dextrose dialysis solution generally yields net fluid removal (ultrafiltration [UF]) volumes of up to 1100 mL/m<sup>2</sup> with acceptable biochemical control. In patients who still have substantial RKF, dialysis solutions of 1.5 percent dextrose may provide acceptable ultrafiltration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients managed by APD, the targeted individual nocturnal fill volume is 1000 to 1200 mL/m<sup>2</sup> for patients &gt;2 years, and 600 to 800 mL/m<sup>2 </sup>for children ≤2 years of age. The daytime fill volume is generally 50 percent of the nighttime volume. The UF using this modality is dependent on cycle frequency, fill volume, osmolality of the dialysis solution, and the transport capacity of the child's peritoneal membrane.</p><p></p><p>Too small a fill volume may lead to rapid solute equilibration and inadequate ultrafiltration [<a href="#rid13">13</a>]. In contrast, too large a volume can lead to excessive increases in intraperitoneal pressure (IPP) that reduces dialysis efficiency due to enhanced lymphatic uptake [<a href="#rid35">35</a>]. In addition, large fill volumes may not be well tolerated by the child due to discomfort/pain, dyspnea, hernia, gastroesophageal reflux, and hydrothorax. In these cases, the IPP measurement may be useful in assessing patient tolerance. In general, an IPP greater than 18 cm H<sub>2</sub>0 is associated with abdominal pain and a decrease in vital capacity [<a href="#rid36">36</a>]. (See <a class="local">'Noninfectious complications'</a> below.)</p><p class="headingAnchor" id="H15616725"><span class="h3">Exchange dwell time</span><span class="headingEndMark"> — </span>The length of the dwell times is dependent on the CPD modality selected.</p><p class="bulletIndent1"><span class="glyph">●</span>In CAPD, the dwell times are long, and therefore the major risk to dialysis efficiency is loss of the glucose-related osmotic gradient due to solute equilibration that results in ineffective ultrafiltration and dialysate reabsorption by the child. Thus, the dwell time may need to be shortened (less than four hours) in children who have high solute transport rates across the peritoneum based on peritoneal equilibration testing. (See <a class="local">'Peritoneal membrane function'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In APD, an exchange dwell time of approximately one hour is initially selected. However, the dwell time needs to be reevaluated and possibly modified based on the needs of the individual patient, taking into consideration the patient's RKF, peritoneal membrane transport function, and the desired clinical goals. Dwell times are shortened to increase ultrafiltration and urea clearance. Long dwell time exchanges, on the other hand, favor higher creatinine and phosphate clearance, but may impair ultrafiltration. Commercially available modeling programs designed to assist in the prescription process have been validated in children [<a href="#rid37">37</a>].</p><p></p><p class="headingAnchor" id="H263453046"><span class="h1">INFECTIOUS COMPLICATIONS</span><span class="headingEndMark"> — </span>Infection is one of the most significant complications of pediatric peritoneal dialysis (PD). The 2022 Annual Data Report from the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.usrds.org%2F2015%2Fview%2FDefault.aspx&amp;token=UBVAQSeX8y0zcV1Zya7DmpCAr4oSe33rNFrko4ol4Y6kFiS2DQEBd9WDbPsgAtz9DK4PLmDZJzYS4D%2BJbltZ4Q%3D%3D&amp;TOPIC_ID=16400" target="_blank">United States Renal Data System</a> (USRDS) reported that infection is second-most common cause of death in children receiving PD [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H15616740"><span class="h2">Peritonitis</span><span class="headingEndMark"> — </span>Peritonitis remains the most common significant complication of CPD in the pediatric population, especially in infants [<a href="#rid39">39,40</a>]. Peritonitis contributes to major morbidity because of loss of peritoneal membrane function and technique failure, particularly in children with repeated episodes of infection [<a href="#rid41">41</a>].</p><p>In the 2011 annual report, the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) reported on 4248 episodes of peritonitis in 6658 years of follow-up for an annualized rate of 0.64 (one episode every 18.8 months) [<a href="#rid21">21</a>]. As seen in earlier reports, the data also revealed an inverse relationship between the age of the patient and peritonitis rate, with the youngest patients (&lt;1 year) having an annualized rate of 0.79 (one infection every 15.3 months), while the adolescents (&gt;12 years) had a rate of 0.57 (one infection every 21.2 months).</p><p>Although the microbiology, diagnosis, and management of peritonitis in children undergoing CPD are similar to those of adult patients, there are some issues that are unique or more common in pediatric CPD. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Fungal peritonitis is an infrequent complication in pediatric patients undergoing CPD, accounting for up to 8 percent of peritonitis episodes [<a href="#rid42">42</a>]. Children with fungal peritonitis are more likely to be less than two years of age. Successful therapy is the same as in adults with fungal peritonitis and consists of combination therapy of antifungal medication and dialysis catheter removal. The outcome of fungal peritonitis in children, however, is more favorable than in adults, with a lower mortality rate [<a href="#rid22">22,43</a>]. (See  <a class="medical medical_review" href="/d/html/1982.html" rel="external">"Fungal peritonitis in peritoneal dialysis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is global variation in causative microbial agents in peritonitis in children receiving CPD [<a href="#rid44">44</a>]. As an example, the rate of <em>Pseudomonas</em>-based peritonitis is eight times greater in the United States than in Europe. In addition, there are significant differences in antibiotic susceptibility, particularly with first generation cephalosporins and aminoglycosides. These issues need to be considered when choosing empiric antibiotic coverage while awaiting results from peritoneal fluid cultures.</p><p></p><p>Predisposing factors in children that may contribute to peritonitis include early use of PD catheter (within 14 days of PD catheter insertion), peritoneal catheter exit-site infection, the higher incidence of gastrostomy feeds, the use of diapers in infants and young children who are not yet toilet trained, and surgical procedures performed around the time of PD catheter placement [<a href="#rid11">11,45</a>]. For example, in a study of infants, nephrectomy at or prior to PD catheter placement and G-tube insertion after catheter placement were associated with nearly six-fold and nearly three-fold increased risk of peritonitis, respectively [<a href="#rid40">40</a>].</p><p>The microbiology, presentation, diagnosis, and management of peritonitis in patients undergoing CPD are discussed separately. (See  <a class="medical medical_review" href="/d/html/1882.html" rel="external">"Microbiology and therapy of peritonitis in peritoneal dialysis"</a> and  <a class="medical medical_review" href="/d/html/1869.html" rel="external">"Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis"</a>.)</p><p class="headingAnchor" id="H15616778"><span class="h2">Exit site and tunnel infections</span><span class="headingEndMark"> — </span>Peritoneal dialysis catheter exit site/tunnel infections are a significant cause of peritonitis and catheter failure [<a href="#rid46">46-48</a>]. A multicenter quality improvement study conducted from 2011 to 2014 reported a rate of exit site and tunnel infections of 0.25 per dialysis year [<a href="#rid46">46</a>]. In this study, peritonitis developed in 6 percent of the cohort, and catheter removal was required in 9 percent of the cases. </p><p>Treatment of catheter exit site infections routinely consists of oral antibiotics according to culture/susceptibility results [<a href="#rid49">49</a>]. Intraperitoneal antibiotics are added only if improvement is not seen promptly. (See  <a class="medical medical_review" href="/d/html/1888.html" rel="external">"Peritoneal catheter exit-site and tunnel infections in peritoneal dialysis in adults"</a>.)</p><p class="headingAnchor" id="H263453219"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>Prevention of exit site infections (ESIs) is the primary goal of exit site care, which consists of aseptic care, daily assessment and cleansing of the exit site, immobilization of the catheter, and protection of the exit site and subcutaneous catheter tunnel from trauma. Proper handwashing technique is of utmost importance and should be practiced by the individual conducting exit site care [<a href="#rid50">50</a>]. Cleansing should be performed with a noncytotoxic and nonalcoholic antiseptic agent, such as sodium hypochlorite or <a class="drug drug_pediatric" data-topicid="13146" href="/d/drug information/13146.html" rel="external">chlorhexidine</a>, as opposed to soap and water. In addition, many centers use topical antibiotic prophylaxis to prevent bacterial infection. As an example, topical <a class="drug drug_pediatric" data-topicid="12622" href="/d/drug information/12622.html" rel="external">mupirocin</a> has been used to decrease <em>S. aureus</em> colonization because of the recognized risk of <em>S. aureus</em> peritonitis in patients with <em>S. aureus</em> nasal carriage.</p><p>The effect of preventive measures to reduce exit site infections and peritonitis was shown in a retrospective review from a single center that reported a reduction in catheter-related infections and prolonged catheter survival with the introduction of daily cleansing with sodium hypochlorite and application of topical <a class="drug drug_pediatric" data-topicid="12622" href="/d/drug information/12622.html" rel="external">mupirocin</a> [<a href="#rid51">51</a>]. However, the association between mupirocin usage and pseudomonas infections has prompted the use of topical <a class="drug drug_pediatric" data-topicid="13332" href="/d/drug information/13332.html" rel="external">gentamicin</a> cream in many centers, as it covers potential gram-positive and the gram-negative pathogens [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/d/html/1888.html" rel="external">"Peritoneal catheter exit-site and tunnel infections in peritoneal dialysis in adults", section on 'Prevention'</a>.)</p><p>Infection prevention can also be achieved through quality improvement initiatives. The SCOPE (Standardizing Care to Improve Outcomes in Pediatric ESKD) collaborative is one such quality improvement initiative that has successfully reduced peritonitis rates from 0.53 episodes per patient year prelaunch to 0.3 at 84 months postlaunch by increasing implementation of standardized care practices [<a href="#rid53">53,54</a>].</p><p class="headingAnchor" id="H15616785"><span class="h1">NONINFECTIOUS COMPLICATIONS</span><span class="headingEndMark"> — </span>Peritoneal dialysis (PD) noninfectious complications can be divided into mechanical, technique-related, and catheter-related complications [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H15616792"><span class="h2">Mechanical complications</span><span class="headingEndMark"> — </span>Mechanical complications of CPD related to increased intraabdominal pressure include hernias, fluid leaks, and hydrothorax [<a href="#rid56">56</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Hernias are commonly incisional, umbilical, or inguinal, occurring with a reported frequency of 11.8 to 53 percent in children undergoing CPD [<a href="#rid57">57-59</a>]. The incidence is inversely proportional to age, with the highest frequency occurring within the first year of life [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/d/html/1865.html" rel="external">"Abdominal wall hernia and dialysate leak in peritoneal dialysis patients"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fluid leaks may occur early (defined as occurring less than 30 days after catheter insertion) or late. Early leaks often occur at the PD catheter exit site, while late leaks more commonly occur into the abdominal wall, leading to abdominal wall or genital edema, and are more likely to be associated with hernias [<a href="#rid60">60</a>]. Leakage is more common in children who weigh less than 10 kg. (See  <a class="medical medical_review" href="/d/html/1883.html" rel="external">"Noninfectious complications of peritoneal dialysis catheters", section on 'Pericatheter leakage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hydrothorax, which may present as an incidental finding on chest x-ray, as respiratory distress without volume overload, or as ultrafiltration failure, is an uncommon but potentially serious complication of CPD. It may result in PD technique failure and the need for transfer to hemodialysis if recurrent. Successful continuation of PD has been reported using reduced fill volumes or following surgical correction of an identified pleuroperitoneal connection; resolution of the hydrothorax may also occasionally occur with temporary cessation of PD. (See  <a class="medical medical_review" href="/d/html/1890.html" rel="external">"Noninfectious complications of continuous peritoneal dialysis", section on 'Pleural effusion due to pleuroperitoneal leak'</a>.)</p><p></p><p class="headingAnchor" id="H15616822"><span class="h2">Technique related complications</span><span class="headingEndMark"> — </span>Ultrafiltration (UF) failure can lead to symptomatic volume overload and PD technique failure, especially in patients who are anephric or oliguric. Decreased ultrafiltration can occur as a result of the following [<a href="#rid55">55</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>High peritoneal membrane solute transport capacity, with rapid dissipation of the glucose-based osmotic gradient for UF. While this may be a chronic issue, it can also arise acutely in patients with peritonitis, which resolves with treatment of the infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Repeated episodes of peritonitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged exposure to glucose degradation products (GDPs) present in conventional PD solutions in patients on long-term PD [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Iatrogenic due to the use of a small fill volume relative to the peritoneal surface area.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased peritoneal lymphatic absorption secondary to elevated intraperitoneal pressure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rarely, aquaporin (ultrasmall pore water channels in the peritoneum) deficiency (see  <a class="medical medical_review" href="/d/html/1878.html" rel="external">"Mechanisms of solute clearance and ultrafiltration in peritoneal dialysis", section on 'Aquaporin-1 and water transport'</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sclerosing encapsulating peritonitis, an outcome that can arise following a prolonged period (years) of PD [<a href="#rid61">61,62</a>] (see <a class="local">'Other complications'</a> below).</p><p></p><p>Performing a peritoneal equilibration test (PET) in patients with UF failure can help better characterize the membrane transport capacity, which will guide PD prescription modifications. (See  <a class="medical medical_review" href="/d/html/1972.html" rel="external">"Peritoneal equilibration test"</a>.)</p><p class="headingAnchor" id="H15616844"><span class="h2">Catheter-related complications</span><span class="headingEndMark"> — </span>Catheter-related complications can occur in the immediate postoperative period or later, and include [<a href="#rid63">63,64</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Leakage of dialysate around the catheter – Delaying catheter usage for one to two weeks following catheter placement or initial use of a small fill volume can decrease the risk of leakage [<a href="#rid65">65</a>]. Two case series from tertiary centers reported that the risk of PD catheter leak was greatest in children who weighed less than 10 to 12.4 kg [<a href="#rid60">60,66</a>]. (See  <a class="medical medical_review" href="/d/html/1883.html" rel="external">"Noninfectious complications of peritoneal dialysis catheters", section on 'Pericatheter leakage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Catheter migration – May occur less commonly with a PD catheter with a curled intraperitoneal segment, swan neck catheter, and a downward-facing exit site [<a href="#rid67">67-69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extrusion of catheter cuff at exit site with subsequent increased risk for infection, which can be prevented by placement of external cuff approximately 2 cm from the exit site [<a href="#rid23">23,70,71</a>]. (See  <a class="medical medical_review" href="/d/html/1883.html" rel="external">"Noninfectious complications of peritoneal dialysis catheters", section on 'Superficial catheter cuff extrusion'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Catheter outflow occlusion, usually caused by omentum, or adhesions to mesentery or other intraabdominal structures. Partial omentectomy is often performed at time of placement in an attempt to prevent catheter outflow occlusion and has been strongly associated with reduced likelihood of PD catheter revision [<a href="#rid24">24,69,72-74</a>]. (See  <a class="medical medical_review" href="/d/html/1883.html" rel="external">"Noninfectious complications of peritoneal dialysis catheters", section on 'Impaired catheter flow'</a>.)</p><p></p><p>Peritoneal dialysis catheter failure can result in the need for access revision. Based on data from the International Pediatric Peritoneal Dialysis Network registry, mechanical dysfunction was the most common indication for access revision within the first year of PD, whereas infectious complications were the predominant cause for revision at &gt;1 year after PD initiation [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H350250243"><span class="h2">Other complications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemoperitoneum</strong> –The incidence of hemoperitoneum as a complication of PD in children is reported to be 1.7 percent [<a href="#rid76">76</a>]. Conventional treatment of hemoperitoneum includes the addition of heparin to the dialysis fluid to prevent catheter occlusion from clots; however, management depends on the severity and underlying cause. The etiology, evaluation, and management of hemoperitoneum in patients undergoing CPD are discussed separately. (See  <a class="medical medical_review" href="/d/html/1923.html" rel="external">"Bloody peritoneal dialysate (hemoperitoneum)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pain</strong> – Abdominal pain can be observed, even in the absence of peritonitis. Causes of abdominal pain include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Jet of dialysis fluid or catheter irritation in the dry peritoneal cavity. The use of a PD catheter with a curled intraperitoneal segment has been associated with a decreased incidence of jet-related pain.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Overdistention of the peritoneal cavity with excessive dialysis fluid due to cycler malfunction or catheter malfunction, and incomplete drainage prior to subsequent filling.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intraabdominal processes unrelated to the dialysis procedure such as peptic ulcer disease, pancreatitis, appendicitis, or diffuse peritoneal calcification. In a case report, tidal peritoneal dialysis effectively provided symptomatic relief of pain in a child with peritoneal calcifications [<a href="#rid77">77</a>].</p><p></p><p class="bulletIndent1">Other causes of pain during dialysate infusion include acidic dialysate fluid, malposition of the catheter, and high glucose concentration of hypertonic dialysis solutions. In addition, referred shoulder pain may occur due to air introduced into the peritoneum during the infusion of dialysis fluid or at the end of draining. (See  <a class="medical medical_review" href="/d/html/1890.html" rel="external">"Noninfectious complications of continuous peritoneal dialysis", section on 'Pain with dialysate infusion or drainage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Encapsulating peritoneal sclerosis</strong>– Encapsulating peritoneal sclerosis (EPS) is a rare, potentially devastating complication of CPD, which leads to progressive loss of UF capacity and can result in abdominal pain, ascites, intestinal obstruction, and death [<a href="#rid78">78,79</a>]. Risk factors implicated in the development of EPS include prolonged duration of peritoneal dialysis, recurrent bacterial peritonitis, and prolonged exposure to hypertonic dialysis solutions [<a href="#rid61">61,62,80-88</a>]. This devastating complication should be suspected when the PET and clinical care shows decreased solute and fluid removal (type II membrane failure). (See  <a class="medical medical_review" href="/d/html/114179.html" rel="external">"Encapsulating peritoneal sclerosis in patients on peritoneal dialysis"</a> and  <a class="medical medical_review" href="/d/html/1972.html" rel="external">"Peritoneal equilibration test"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutritional and metabolic issues ‒</strong> Nutritional and metabolic issues associated with CPD include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Protein loss. (See  <a class="medical medical_review" href="/d/html/1855.html" rel="external">"Nutritional status and protein intake in patients on peritoneal dialysis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hyponatremia due to sodium loss, which may result in significant hypovolemia and hypotension. Case reports in infants and young children undergoing CPD suggest that hypovolemia and hypotension may contribute to developing anterior ischemic optic neuropathy [<a href="#rid89">89,90</a>]. (See  <a class="medical medical_review" href="/d/html/1878.html" rel="external">"Mechanisms of solute clearance and ultrafiltration in peritoneal dialysis", section on 'Electrolytes'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypothyroidism has been reported as a complication of chronic exposure to povidone-iodine-impregnated gauze from the transfer set [<a href="#rid91">91</a>]. (See  <a class="medical medical_review" href="/d/html/1977.html" rel="external">"Thyroid function in chronic kidney disease", section on 'Thyroid hormone metabolism'</a>.)</p><p></p><p class="headingAnchor" id="H15616851"><span class="h1">OUTCOME</span></p><p class="headingAnchor" id="H15616859"><span class="h2">Patient survival</span><span class="headingEndMark"> — </span>Patient mortality rates in children receiving CPD are significantly greater than the rates in transplanted children or the healthy population. Among nearly 3000 patients from the International Pediatric Peritoneal Dialysis Network (IPPN) cohort between 1996 and 2017, the mortality rate globally was 5 percent over three years follow-up [<a href="#rid92">92</a>]. The lowest rate was in North America (2 percent) and the highest in Eastern Europe (9 percent); the difference was largely related to disparate resources.</p><p>The most common causes of death for pediatric CPD patients of all ages are cardiovascular disease and infection [<a href="#rid93">93-96</a>]. Pulmonary disease and severe oliguria/anuria appear to be significant risk factors for mortality in young children and infants.</p><p class="headingAnchor" id="H1454289269"><span class="h3">Young children</span><span class="headingEndMark"> — </span>Survival rate is lowest in children below five years of age as noted by the following: </p><p class="bulletIndent1"><span class="glyph">●</span>In the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.usrds.org%2F2015%2Fview%2FDefault.aspx&amp;token=UBVAQSeX8y0zcV1Zya7DmpCAr4oSe33rNFrko4ol4Y6kFiS2DQEBd9WDbPsgAtz9DK4PLmDZJzYS4D%2BJbltZ4Q%3D%3D&amp;TOPIC_ID=16400" target="_blank">United States Renal Data System</a> (USRDS) 2022 Annual Data Report, five-year survival was reported to be lowest in the &lt;1 year age group, at approximately 79 percent, followed by children aged one to five years old, at approximately 89 percent [<a href="#rid38">38</a>]. In contrast, survival in the ≥6-year age group was 96 percent. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Data from the Italian dialysis registry has also documented the highest mortality rates in the youngest patients (&lt;5 years of age) [<a href="#rid97">97</a>].</p><p></p><p class="headingAnchor" id="H415445400"><span class="h3">Infants</span><span class="headingEndMark"> — </span>Data from the USRDS showed a mortality of 21 percent while on dialysis for infants who initiated chronic PD at ≤12 months of age from 1990 to 2014 [<a href="#rid98">98</a>]. For infants who started PD as neonates, survival improved during the period between 2000 to 2014 compared with the earlier time period 1990 to 1999 for both one-year survival (87 versus 77 percent) and five-year survival (75 versus 64 percent). Similar results were reported for older infants who initiated PD at 1 to &lt;12 months for one-year survival (90 versus 81 percent) and five-year survival (79 versus 62 percent). The two most common causes of death based on reports of 273 of the 360 patient deaths were cardiorespiratory failure (26 percent) and infection (23 percent).</p><p>Data from the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) also showed that the three-year patient survival improved from 79 to 85 percent for infants initiating CPD during the first year of life in 1992 to 1999 and 2000 to 2012 [<a href="#rid99">99</a>]. </p><p>The European Registry for Paediatric Nephrology also reported increasing mortality for infants with decreasing age with a 5 percent increased risk of death per month of earlier initiation during the first year of life [<a href="#rid100">100</a>].</p><p class="headingAnchor" id="H263453462"><span class="h2">Transition to hemodialysis</span><span class="headingEndMark"> — </span>The need to terminate CPD for reasons other than transplantation is most commonly the result of infectious complications. A North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) study found that 20 percent of patients transitioned from CPD to hemodialysis (HD) over a six-year period, most commonly (43 percent) due to infection, followed by ultrafiltration failure, patient/family choice, and access failure [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H2558652261"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110751.html" rel="external">"Society guideline links: Chronic kidney disease in children"</a>.)</p><p class="headingAnchor" id="H263453553"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Advantages and disadvantages of chronic peritoneal dialysis – </strong>Chronic peritoneal dialysis (CPD) is the most common dialysis treatment modality used to treat pediatric patients with end-stage kidney disease (ESKD), particularly in children less than six years of age. There are no comparative studies of chronic peritoneal dialysis (CPD) and hemodialysis (HD) outcomes in children with ESKD to suggest superiority of one procedure versus the other. Advantages associated with CPD include a less restricted diet, ability to perform dialysis treatments at home, and no need for vascular access and repeated venipuncture. Disadvantages of CPD include increased caregiver burden and risks of potential nonadherence, and CPD related infections. Contraindications to CPD include specific conditions that affect the integrity of the abdominal cavity and peritoneum. (See <a class="local">'Peritoneal dialysis versus hemodialysis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CPD prescription</strong> – Selection of the CPD modality and the specific prescription should ideally be tailored to the needs of the individual patient, with consideration of the medical needs of the child and the quality of life of the patient and family. These choices are based on the child's age, body size, associated nonrenal diseases, nutritional status, and transport characteristics of the peritoneal membrane, as well as the social, educational, and economic status of the family. (See <a class="local">'Prescribing peritoneal dialysis'</a> above.)</p><p></p><p class="bulletIndent1">The elements of the CPD prescription include selection of PD solutions and determination of the fill volume, dwell time, and the number of exchanges. The prescription is based on the individual patient needs for solute transport and removal of fluid, both of which can be increased by changes in the prescription, such as increasing the osmolality of the solution, fill volume, and/or number of exchanges. (See <a class="local">'Prescription components'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CPD modalities </strong>– These are divided into manual and automated options:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continuous ambulatory PD (CAPD) is the manual form of CPD that provides continuous solute and fluid removal throughout the day and night. It is easier to use and less costly than the automated PD options. (See <a class="local">'Continuous ambulatory PD'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Automated PD (APD) uses a cycler that performs multiple exchanges at night. It allows for a wide range of treatment options, which can be more easily tailored to the patient's needs than CAPD. The three options of APD are nightly intermittent PD, continuous cycling PD, and tidal peritoneal dialysis. (See <a class="local">'Automated PD'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Catheter placement</strong> – Successful CPD is dependent on the placement of a reliable access. In the pediatric patient, we suggest using a two-cuffed Tenckhoff catheter rather than a single-cuffed catheter to reduce the risk of peritonitis (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). Placement of the catheter with a lateral or downward-pointed exit site position also reduces the risk of peritonitis. (See <a class="local">'PD catheter'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessing peritoneal membrane function</strong> – We suggest that a peritoneal equilibration test (PET) be performed in all children undergoing CPD to determine the solute transport characteristics of the peritoneal membrane, which can assist in developing an adequate dialysis prescription (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Test fill volume is determined by the body surface area of the child. (See <a class="local">'Peritoneal membrane function'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infectious complications</strong> – These include peritonitis and catheter exit site/tunnel infections. We recommend daily care of the exit site and catheter that reduces the risk of exit site and tunnel infections (<a class="grade" href="https://medilib.ir/uptodate/show/grade_3" rel="external">Grade 1C</a>). This includes proper handwashing by the care provider, daily assessment and cleansing of the exit site with antiseptic agents, catheter immobilization, trauma avoidance to the exit site and subcutaneous catheter, and the use of topical antibiotic prophylaxis. (See <a class="local">'Infectious complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Noninfectious complications</strong> – These include: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mechanical complications due to increased intraperitoneal pressure include hernia, fluid leak, and hydrothorax. (See <a class="local">'Mechanical complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Technique-related complications include ultrafiltration failure, which may be due to rapid solute transport, increased lymphatic flow, or aquaporin deficiency. (See <a class="local">'Technique related complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Catheter-related complications include dialysate leakage, catheter migration, cuff extrusion, and outflow occlusion. (See <a class="local">'Catheter-related complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other complications include hemoperitoneum, pain, sclerosing encapsulating peritonitis, and nutritional and metabolic problems. (See <a class="local">'Other complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – Patient mortality rates in children receiving CPD are significantly greater than the rates in transplanted children or the healthy population. The most common causes of death for pediatric CPD patients of all ages are cardiovascular disease and infection. Mortality is highest in young children (below five years of age) and infants. Pulmonary disease and severe oliguria/anuria appear to be significant risk factors for mortality in infants and young children. (See <a class="local">'Patient survival'</a> above.)</p><p></p><p class="bulletIndent1">The need to terminate CPD and transition to HD is most commonly the result of infectious complications. (See <a class="local">'Transition to hemodialysis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hattori S, Yosioka K, Honda M, et al. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol 2002; 17:456.</a></li><li><a class="nounderline abstract_t">Verrina E, Edefonti A, Gianoglio B, et al. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol 2004; 19:82.</a></li><li><a class="nounderline abstract_t">Fadrowski JJ, Frankenfield D, Amaral S, et al. Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project. Am J Kidney Dis 2007; 50:958.</a></li><li><a class="nounderline abstract_t">Warady BA, Alexander SR, Watkins S, et al. Optimal care of the pediatric end-stage renal disease patient on dialysis. Am J Kidney Dis 1999; 33:567.</a></li><li><a class="nounderline abstract_t">Verrina E, Cappelli V, Perfumo F. Selection of modalities, prescription, and technical issues in children on peritoneal dialysis. Pediatr Nephrol 2009; 24:1453.</a></li><li><a class="nounderline abstract_t">Favel K, Dionne JM. Factors influencing the timing of initiation of renal replacement therapy and choice of modality in children with end-stage kidney disease. Pediatr Nephrol 2020; 35:145.</a></li><li class="breakAll">Verrina E. Peritoneal Dialysis. In: Pediatric Nephrology, Avner ED HW, Niaudet P, Yoshikawa N (Eds), Springer-Verlag, Berlin Heidelberg 2009. p.1785.</li><li><a class="nounderline abstract_t">Tsai TC, Liu SI, Tsai JD, Chou LH. Psychosocial effects on caregivers for children on chronic peritoneal dialysis. Kidney Int 2006; 70:1983.</a></li><li><a class="nounderline abstract_t">Wightman A, Zimmerman CT, Neul S, et al. Caregiver Experience in Pediatric Dialysis. Pediatrics 2019; 143.</a></li><li><a class="nounderline abstract_t">Dolan NM, Borzych-Duzalka D, Suarez A, et al. Ventriculoperitoneal shunts in children on peritoneal dialysis: a survey of the International Pediatric Peritoneal Dialysis Network. Pediatr Nephrol 2013; 28:315.</a></li><li><a class="nounderline abstract_t">Chan EYH, Borzych-Duzalka D, Alparslan C, et al. Colostomy in children on chronic peritoneal dialysis. Pediatr Nephrol 2020; 35:119.</a></li><li><a class="nounderline abstract_t">Wisanuyotin S, Dell KM, Vogt BA, et al. Complications of peritoneal dialysis in children with Eagle-Barrett syndrome. Pediatr Nephrol 2003; 18:159.</a></li><li><a class="nounderline abstract_t">Fischbach M, Warady BA. Peritoneal dialysis prescription in children: bedside principles for optimal practice. Pediatr Nephrol 2009; 24:1633.</a></li><li><a class="nounderline abstract_t">Warady BA, Schaefer F, Bagga A, et al. Prescribing peritoneal dialysis for high-quality care in children. Perit Dial Int 2020; 40:333.</a></li><li><a class="nounderline abstract_t">Prasad N, Rangaswamy D, Patel M, et al. Long-term outcomes in children on chronic continuous ambulatory peritoneal dialysis: a retrospective cohort study from a developing country. Pediatr Nephrol 2019; 34:2389.</a></li><li class="breakAll">North American Pediatric Renal Trials and Cooperative Studies (NAPRTCS). 2008 Annual Report. Rockville: EMMES Corporation, 2008.</li><li><a class="nounderline abstract_t">Hölttä T, Rönnholm K, Holmberg C. Adequacy of dialysis with tidal and continuous cycling peritoneal dialysis in children. Nephrol Dial Transplant 2000; 15:1438.</a></li><li><a class="nounderline abstract_t">Chua AN, Warady BA. Adherence of pediatric patients to automated peritoneal dialysis. Pediatr Nephrol 2011; 26:789.</a></li><li><a class="nounderline abstract_t">Milan Manani S, Crepaldi C, Giuliani A, et al. Remote Monitoring of Automated Peritoneal Dialysis Improves Personalization of Dialytic Prescription and Patient's Independence. Blood Purif 2018; 46:111.</a></li><li><a class="nounderline abstract_t">Fischbach M, Schmitt CP, Shroff R, et al. Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription. Kidney Int 2016; 89:761.</a></li><li class="breakAll">North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS 2011 Annual Report: renal transplantation, dialysis, chronic renal insufficiency. www.emmes.com/study/ped/annlrept/annualrept2011.pdf (Accessed on June 01, 2011).</li><li><a class="nounderline abstract_t">Sethna CB, Bryant K, Munshi R, et al. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative. Clin J Am Soc Nephrol 2016; 11:1590.</a></li><li><a class="nounderline abstract_t">Crabtree JH, Shrestha BM, Chow KM, et al. Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update. Perit Dial Int 2019; 39:414.</a></li><li><a class="nounderline abstract_t">Schuh MP, Nehus E, Liu C, et al. Omentectomy reduces the need for peritoneal dialysis catheter revision in children: a study from the Pediatric Nephrology Research Consortium. Pediatr Nephrol 2021; 36:3953.</a></li><li><a class="nounderline abstract_t">Warady BA, Alexander SR, Hossli S, et al. Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 1996; 7:2385.</a></li><li><a class="nounderline abstract_t">Warady BA, Alexander S, Hossli S, et al. The relationship between intraperitoneal volume and solute transport in pediatric patients. Pediatric Peritoneal Dialysis Study Consortium. J Am Soc Nephrol 1995; 5:1935.</a></li><li><a class="nounderline abstract_t">de Boer AW, van Schaijk TC, Willems HL, et al. The necessity of adjusting dialysate volume to body surface area in pediatric peritoneal equilibration tests. Perit Dial Int 1997; 17:199.</a></li><li><a class="nounderline abstract_t">Bouts AH, Davin JC, Groothoff JW, et al. Standard peritoneal permeability analysis in children. J Am Soc Nephrol 2000; 11:943.</a></li><li><a class="nounderline abstract_t">Bartosova M, Schaefer B, Vondrak K, et al. Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD. Front Physiol 2019; 10:356.</a></li><li><a class="nounderline abstract_t">Schmitt CP, Nau B, Gemulla G, et al. Effect of the dialysis fluid buffer on peritoneal membrane function in children. Clin J Am Soc Nephrol 2013; 8:108.</a></li><li><a class="nounderline abstract_t">Schaefer B, Bartosova M, Macher-Goeppinger S, et al. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis. Kidney Int 2018; 94:419.</a></li><li><a class="nounderline abstract_t">Schröder CH. New peritoneal dialysis fluids: practical use for children. Pediatr Nephrol 2003; 18:1085.</a></li><li><a class="nounderline abstract_t">Canepa A, Verrina E, Perfumo F. Use of new peritoneal dialysis solutions in children. Kidney Int Suppl 2008; :S137.</a></li><li><a class="nounderline abstract_t">Rousso S, Banh TM, Ackerman S, et al. Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis. Pediatr Nephrol 2016; 31:1673.</a></li><li><a class="nounderline abstract_t">Fischbach M, Terzic J, Menouer S, et al. Impact of fill volume changes on peritoneal dialysis tolerance and effectiveness in children. Adv Perit Dial 2000; 16:321.</a></li><li><a class="nounderline abstract_t">Fischbach M, Dheu C, Seugé-Dargnies L, Delobbe JF. Adequacy of peritoneal dialysis in children: consider the membrane for optimal prescription. Perit Dial Int 2007; 27 Suppl 2:S167.</a></li><li><a class="nounderline abstract_t">Warady BA, Watkins SL, Fivush BA, et al. Validation of PD Adequest 2.0 for pediatric dialysis patients. Pediatr Nephrol 2001; 16:205.</a></li><li class="breakAll">2022 USRDS Annual Report United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2022.</li><li><a class="nounderline abstract_t">Warady BA, Sullivan EK, Alexander SR. Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int Suppl 1996; 53:S68.</a></li><li><a class="nounderline abstract_t">Zaritsky JJ, Hanevold C, Quigley R, et al. Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy: a report of the SCOPE collaborative. Pediatr Nephrol 2018; 33:713.</a></li><li><a class="nounderline abstract_t">Warady BA, Feneberg R, Verrina E, et al. Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol 2007; 18:2172.</a></li><li><a class="nounderline abstract_t">Munshi R, Sethna CB, Richardson T, et al. Fungal peritonitis in the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative. Pediatr Nephrol 2018; 33:873.</a></li><li><a class="nounderline abstract_t">Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int 2000; 58:384.</a></li><li><a class="nounderline abstract_t">Schaefer F, Feneberg R, Aksu N, et al. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 2007; 72:1374.</a></li><li><a class="nounderline abstract_t">Keswani M, Redpath Mahon AC, Richardson T, et al. Risk factors for early onset peritonitis: the SCOPE collaborative. Pediatr Nephrol 2019; 34:1387.</a></li><li><a class="nounderline abstract_t">Swartz SJ, Neu A, Skversky Mason A, et al. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative. Pediatr Nephrol 2018; 33:1029.</a></li><li><a class="nounderline abstract_t">Furth SL, Donaldson LA, Sullivan EK, et al. Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 2000; 15:179.</a></li><li><a class="nounderline abstract_t">Aksu N, Yavascan O, Anil M, et al. A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters. Nephrol Dial Transplant 2007; 22:2045.</a></li><li><a class="nounderline abstract_t">Warady BA, Bakkaloglu S, Newland J, et al. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int 2012; 32 Suppl 2:S32.</a></li><li><a class="nounderline abstract_t">Pittet D, Allegranzi B, Boyce J, World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts. The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect Control Hosp Epidemiol 2009; 30:611.</a></li><li><a class="nounderline abstract_t">Chua AN, Goldstein SL, Bell D, Brewer ED. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin J Am Soc Nephrol 2009; 4:1939.</a></li><li><a class="nounderline abstract_t">Bernardini J, Bender F, Florio T, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16:539.</a></li><li><a class="nounderline abstract_t">Neu AM, Richardson T, Lawlor J, et al. Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. Kidney Int 2016; 89:1346.</a></li><li><a class="nounderline abstract_t">Neu AM, Richardson T, De Souza HG, et al. Continued reduction in peritonitis rates in pediatric dialysis centers: results of the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative. Pediatr Nephrol 2021; 36:2383.</a></li><li class="breakAll">Harvey E. Non-infectious complications of peritoneal dialysis and hemodialysis. In: Pediatric Dialysis, Warady BA, Schaefer F, Fine RN, Alexander SR (Eds), Kluwer Academic Publishers, Dordrecht 2004. p.415.</li><li><a class="nounderline abstract_t">Bargman JM. Complications of peritoneal dialysis related to increased intraabdominal pressure. Kidney Int Suppl 1993; 40:S75.</a></li><li><a class="nounderline abstract_t">von Lilien T, Salusky IB, Yap HK, et al. Hernias: a frequent complication in children treated with continuous peritoneal dialysis. Am J Kidney Dis 1987; 10:356.</a></li><li><a class="nounderline abstract_t">van Asseldonk JP, Schröder CH, Severijnen RS, et al. Infectious and surgical complications of childhood continuous ambulatory peritoneal dialysis. Eur J Pediatr 1992; 151:377.</a></li><li><a class="nounderline abstract_t">Hölttä TM, Rönnholm KA, Jalanko H, et al. Peritoneal dialysis in children under 5 years of age. Perit Dial Int 1997; 17:573.</a></li><li><a class="nounderline abstract_t">Radtke J, Lemke A, Kemper MJ, et al. Surgical complications after peritoneal dialysis catheter implantation depend on children's weight. J Pediatr Surg 2016; 51:1317.</a></li><li><a class="nounderline abstract_t">Stefanidis CJ, Shroff R. Encapsulating peritoneal sclerosis in children. Pediatr Nephrol 2014; 29:2093.</a></li><li><a class="nounderline abstract_t">Vidal E, Edefonti A, Puteo F, et al. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis. Nephrol Dial Transplant 2013; 28:1603.</a></li><li class="breakAll">Brandt M, Brewer E. Peritoneal dialysis access in children. In: Pediatric Dialysis, Warady BA, Schaefer F, Fine RN, Alexander SR (Eds), Kluwer Academic Publishers, Dordrecht 2004. p.83.</li><li><a class="nounderline abstract_t">Phan J, Stanford S, Zaritsky JJ, DeUgarte DA. Risk factors for morbidity and mortality in pediatric patients with peritoneal dialysis catheters. J Pediatr Surg 2013; 48:197.</a></li><li><a class="nounderline abstract_t">Twardowski ZJ, Prowant BF. Exit-site healing post catheter implantation. Perit Dial Int 1996; 16 Suppl 3:S51.</a></li><li><a class="nounderline abstract_t">Stewart CL, Acker SN, Pyle LL, et al. Factors associated with peritoneal dialysis catheter complications in children. J Pediatr Surg 2016; 51:159.</a></li><li><a class="nounderline abstract_t">Twardowski ZJ, Prowant BF, Nichols WK, et al. Six-year experience with swan neck catheters. Perit Dial Int 1992; 12:384.</a></li><li><a class="nounderline abstract_t">Hwang TL, Huang CC. Comparison of Swan neck catheter with Tenckhoff catheter for CAPD. Adv Perit Dial 1994; 10:203.</a></li><li><a class="nounderline abstract_t">Harvey EA. Peritoneal access in children. Perit Dial Int 2001; 21 Suppl 3:S218.</a></li><li><a class="nounderline abstract_t">Flanigan M, Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit Dial Int 2005; 25:132.</a></li><li><a class="nounderline abstract_t">Campos RP, Chula DC, Riella MC. Complications of the peritoneal access and their management. Contrib Nephrol 2009; 163:183.</a></li><li><a class="nounderline abstract_t">Conlin MJ, Tank ES. Minimizing surgical problems of peritoneal dialysis in children. J Urol 1995; 154:917.</a></li><li><a class="nounderline abstract_t">Ladd AP, Breckler FD, Novotny NM. Impact of primary omentectomy on longevity of peritoneal dialysis catheters in children. Am J Surg 2011; 201:401.</a></li><li><a class="nounderline abstract_t">Cribbs RK, Greenbaum LA, Heiss KF. Risk factors for early peritoneal dialysis catheter failure in children. J Pediatr Surg 2010; 45:585.</a></li><li><a class="nounderline abstract_t">Borzych-Duzalka D, Aki TF, Azocar M, et al. Peritoneal Dialysis Access Revision in Children: Causes, Interventions, and Outcomes. Clin J Am Soc Nephrol 2017; 12:105.</a></li><li><a class="nounderline abstract_t">Rinaldi S, Sera F, Verrina E, et al. The Italian Registry of Pediatric Chronic Peritoneal Dialysis: a ten-year experience with chronic peritoneal dialysis catheters. Perit Dial Int 1998; 18:71.</a></li><li><a class="nounderline abstract_t">Warady BA, Bohl V, Alon U, Hellerstein S. Symptomatic peritoneal calcification in a child: treatment with tidal peritoneal dialysis. Perit Dial Int 1994; 14:26.</a></li><li><a class="nounderline abstract_t">Brown EA, Bargman J, van Biesen W, et al. Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update. Perit Dial Int 2017; 37:362.</a></li><li><a class="nounderline abstract_t">Tan FL, Loh D, Prabhakaran K. Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis. J Pediatr Surg 2005; 40:e21.</a></li><li><a class="nounderline abstract_t">Araki Y, Hataya H, Tanaka Y, et al. Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int 2000; 20:445.</a></li><li><a class="nounderline abstract_t">Slingeneyer A, Mion C, Mourad G, et al. Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis. Trans Am Soc Artif Intern Organs 1983; 29:633.</a></li><li><a class="nounderline abstract_t">Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14.</a></li><li><a class="nounderline abstract_t">Campbell S, Clarke P, Hawley C, et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features. Am J Kidney Dis 1994; 24:819.</a></li><li><a class="nounderline abstract_t">Nomoto Y, Kawaguchi Y, Kubo H, et al. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28:420.</a></li><li><a class="nounderline abstract_t">Mactier RA. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis. Adv Perit Dial 2000; 16:223.</a></li><li><a class="nounderline abstract_t">Nakayama M, Yamamoto H, Ikeda M, et al. Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002. Adv Perit Dial 2002; 18:144.</a></li><li><a class="nounderline abstract_t">Woodrow G, Fan SL, Reid C, et al. Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children. BMC Nephrol 2017; 18:333.</a></li><li><a class="nounderline abstract_t">Shroff R, Stefanidis CJ, Askiti V, et al. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Nephrol Dial Transplant 2013; 28:1908.</a></li><li><a class="nounderline abstract_t">Dufek S, Feldkoetter M, Vidal E, et al. Anterior ischemic optic neuropathy in pediatric peritoneal dialysis: risk factors and therapy. Pediatr Nephrol 2014; 29:1249.</a></li><li><a class="nounderline abstract_t">Fischbach M, Zaloszyc A, Schaefer B, Schmitt CP. Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume. Pediatr Nephrol 2014; 29:1321.</a></li><li><a class="nounderline abstract_t">Mannemuddhu SS, Morgans HA, Pekkucuksen NT, et al. Hypothyroidism Due to Iodine Overload in Children Receiving Peritoneal Dialysis: A Report of 4 Cases. Am J Kidney Dis 2020; 76:889.</a></li><li><a class="nounderline abstract_t">Ploos van Amstel S, Noordzij M, Borzych-Duzalka D, et al. Mortality in Children Treated With Maintenance Peritoneal Dialysis: Findings From the International Pediatric Peritoneal Dialysis Network Registry. Am J Kidney Dis 2021; 78:380.</a></li><li class="breakAll">United States Renal Data System, USRDS 2009 Annual Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, 2009.</li><li><a class="nounderline abstract_t">Shroff R, Rees L, Trompeter R, et al. Long-term outcome of chronic dialysis in children. Pediatr Nephrol 2006; 21:257.</a></li><li><a class="nounderline abstract_t">Rees L. Long-term peritoneal dialysis in infants. Perit Dial Int 2007; 27 Suppl 2:S180.</a></li><li><a class="nounderline abstract_t">Shroff R, Ledermann S. Long-term outcome of chronic dialysis in children. Pediatr Nephrol 2009; 24:463.</a></li><li><a class="nounderline abstract_t">Rinaldi S, Sera F, Verrina E, et al. Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit Dial Int 2004; 24:481.</a></li><li><a class="nounderline abstract_t">Sanderson KR, Yu Y, Dai H, et al. Outcomes of infants receiving chronic peritoneal dialysis: an analysis of the USRDS registry. Pediatr Nephrol 2019; 34:155.</a></li><li><a class="nounderline abstract_t">Carey WA, Martz KL, Warady BA. Outcome of Patients Initiating Chronic Peritoneal Dialysis During the First Year of Life. Pediatrics 2015; 136:e615.</a></li><li><a class="nounderline abstract_t">Vidal E, van Stralen KJ, Chesnaye NC, et al. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis. Am J Kidney Dis 2017; 69:617.</a></li></ol></div><div id="topicVersionRevision">Topic 16400 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12107812" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14648343" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A multicenter experience on patient and technique survival in children on chronic dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18037097" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10070923" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Optimal care of the pediatric end-stage renal disease patient on dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18521632" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Selection of modalities, prescription, and technical issues in children on peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31654222" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Factors influencing the timing of initiation of renal replacement therapy and choice of modality in children with end-stage kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31654222" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Factors influencing the timing of initiation of renal replacement therapy and choice of modality in children with end-stage kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16985519" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Psychosocial effects on caregivers for children on chronic peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30696758" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Caregiver Experience in Pediatric Dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22972407" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ventriculoperitoneal shunts in children on peritoneal dialysis: a survey of the International Pediatric Peritoneal Dialysis Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31673828" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Colostomy in children on chronic peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12579407" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Complications of peritoneal dialysis in children with Eagle-Barrett syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18807074" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Peritoneal dialysis prescription in children: bedside principles for optimal practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32063210" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prescribing peritoneal dialysis for high-quality care in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31468143" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Long-term outcomes in children on chronic continuous ambulatory peritoneal dialysis: a retrospective cohort study from a developing country.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31468143" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Long-term outcomes in children on chronic continuous ambulatory peritoneal dialysis: a retrospective cohort study from a developing country.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10978404" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Adequacy of dialysis with tidal and continuous cycling peritoneal dialysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21350797" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Adherence of pediatric patients to automated peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29694954" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Remote Monitoring of Automated Peritoneal Dialysis Improves Personalization of Dialytic Prescription and Patient's Independence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26924063" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26924063" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27340282" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31028108" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34128096" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Omentectomy reduces the need for peritoneal dialysis catheter revision in children: a study from the Pediatric Nephrology Research Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8959629" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Peritoneal membrane transport function in children receiving long-term dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7620091" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The relationship between intraperitoneal volume and solute transport in pediatric patients. Pediatric Peritoneal Dialysis Study Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9159845" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The necessity of adjusting dialysate volume to body surface area in pediatric peritoneal equilibration tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10770974" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Standard peritoneal permeability analysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31001140" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23124784" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Effect of the dialysis fluid buffer on peritoneal membrane function in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29776755" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15212043" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : New peritoneal dialysis fluids: practical use for children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18379537" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Use of new peritoneal dialysis solutions in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27178072" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11045320" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Impact of fill volume changes on peritoneal dialysis tolerance and effectiveness in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17556298" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Adequacy of peritoneal dialysis in children: consider the membrane for optimal prescription.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11322365" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Validation of PD Adequest 2.0 for pediatric dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11322365" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Validation of PD Adequest 2.0 for pediatric dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8770994" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29150711" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy: a report of the SCOPE collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17582162" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29313137" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Fungal peritonitis in the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10886585" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17882152" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Worldwide variation of dialysis-associated peritonitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30969363" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Risk factors for early onset peritonitis: the SCOPE collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29480421" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11214588" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17438008" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22851742" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19508124" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19820132" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15625071" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27165827" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33649895" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Continued reduction in peritonitis rates in pediatric dialysis centers: results of the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33649895" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Continued reduction in peritonitis rates in pediatric dialysis centers: results of the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8445842" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Complications of peritoneal dialysis related to increased intraabdominal pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3674009" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Hernias: a frequent complication in children treated with continuous peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1396895" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Infectious and surgical complications of childhood continuous ambulatory peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9655157" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Peritoneal dialysis in children under 5 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26775194" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Surgical complications after peritoneal dialysis catheter implantation depend on children's weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24258273" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Encapsulating peritoneal sclerosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23585587" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23585587" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23331815" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Risk factors for morbidity and mortality in pediatric patients with peritoneal dialysis catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8860150" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Exit-site healing post catheter implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26572851" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Factors associated with peritoneal dialysis catheter complications in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1420498" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Six-year experience with swan neck catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7999828" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Comparison of Swan neck catheter with Tenckhoff catheter for CAPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11887825" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Peritoneal access in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15796138" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19494613" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Complications of the peritoneal access and their management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7609212" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Minimizing surgical problems of peritoneal dialysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21367387" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Impact of primary omentectomy on longevity of peritoneal dialysis catheters in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20223324" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Risk factors for early peritoneal dialysis catheter failure in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27899416" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Peritoneal Dialysis Access Revision in Children: Causes, Interventions, and Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9527033" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The Italian Registry of Pediatric Chronic Peritoneal Dialysis: a ten-year experience with chronic peritoneal dialysis catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8312409" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Symptomatic peritoneal calcification in a child: treatment with tidal peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28676507" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15937801" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11007377" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6673302" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1347465" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977325" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8804242" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11045299" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12402607" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29145808" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23348882" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24488506" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Anterior ischemic optic neuropathy in pediatric peritoneal dialysis: risk factors and therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23903692" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32471796" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Hypothyroidism Due to Iodine Overload in Children Receiving Peritoneal Dialysis: A Report of 4 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33549627" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Mortality in Children Treated With Maintenance Peritoneal Dialysis: Findings From the International Pediatric Peritoneal Dialysis Network Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33549627" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Mortality in Children Treated With Maintenance Peritoneal Dialysis: Findings From the International Pediatric Peritoneal Dialysis Network Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16270221" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Long-term outcome of chronic dialysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17556301" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Long-term peritoneal dialysis in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18214549" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Long-term outcome of chronic dialysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15490990" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30141177" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Outcomes of infants receiving chronic peritoneal dialysis: an analysis of the USRDS registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26304827" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Outcome of Patients Initiating Chronic Peritoneal Dialysis During the First Year of Life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27955924" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
